QualityStocksNewsBreaks Archives - Page 416 of 1453

MondayAug 29, 2022 11:01 am

QualityStocksNewsBreaks – Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) Acquires Santiago, Chile-Based CUATROi

Cerberus Sentinel (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider based in Scottsdale, Arizona, today announced its completion of the acquisition of CUATROi. Under the terms of the agreement, CUATROi, a cloud, managed services provider and cybersecurity company with headquarters in Santiago, Chile, and offices in Bogotá, Colombia and Lima, Peru, became a wholly owned subsidiary of Cerberus Sentinel. “CUATROi is an excellent cultural fit with the Cerberus Sentinel family of companies,” said David Jemmett, CEO and founder of Cerberus Sentinel. “Cybersecurity is a worldwide problem that requires global capabilities to address the security demands of…

FridayAug 26, 2022 1:59 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) on Target to Own, Control ‘the Elements’ to Supply EV, Renewable Energy, Other Technology Manufacturers

Energy Fuels (NYSE American: UUUU) (TSX: EFR) recently entered into binding agreements to acquire 17 mineral concessions in Brazil. A recent article reads: “The acquisitions, located in the state of Bahia and total approximately 58 square miles, have the potential to provide UUUU’s White Mesa Mill with large quantities of rare-earth-element and uranium-bearing natural monazite sand for decades. “This is another very significant step in Energy Fuels’ development as a major global rare earth element producer based in the United States,” said Energy Fuels CEO and President Mark Chalmers. “We are aggressively seeking to expand our monazite sand feeds. With…

FridayAug 26, 2022 1:09 pm

QualityStocksNewsBreaks – Odyssey Health Inc.’s (ODYY) PRV-002 Poised to Offer First-of-Its-Kind Responsiveness to Concussion

Odyssey Health (OTC: ODYY), a medical device innovator and biopharmaceutical product developer, has been advancing a proposed solution for brain injury from concussive forces. “Odyssey Health’s novel compound PRV-002 is the combination of a device and the medicine it delivers to treat concussions during the first moments after their occurrence, before permanent or long-term damage can set in. No U.S. Food and Drug Administration (‘FDA’)-approved drug treatment exists for concussion, and medical providers are generally left to rely on prescribed rest to help patients recover. But if Odyssey’s product can be established as safe and effective, it will open doors…

FridayAug 26, 2022 12:58 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Lays Strong Foundation in ‘Seed-to-Market’ Approach

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) has explored various sectors, including precision fermentation and regenerative agriculture, with the overall goal of investing in the entire plant-based supply chain in what it describes as a “seed-to-market” approach. “This outlook has seen Eat Well grow its portfolio significantly over the past few years, even securing awards for its pulse processing… Eat Well has made significant investments in the Consumer Packaged Goods (‘CPG’), food technology, agribusiness, and the media sectors, all of which serve to diversify its product and service offerings, as well as its revenue earnings. Most of all, these…

FridayAug 26, 2022 12:44 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Leveraging Ultimate ‘Anti-Label’ Solution to Fill Gaps Faced by Independent Artists

Friendable (OTC: FDBL), a mobile technology and marketing company, released its flagship offering, Fan Pass Live artist platform, in July 2020. “Now, Friendable’s Fan Pass Live has become the 360-degree offering for independent artists, offering music production, distribution and marketing with the acquisition of Artist Republik and FeaturedX in January 2022. The company has identified the gaps independent artists face in the industry and has developed the ultimate ‘anti-label’ solution,” a recent article reads. “Fan Pass Live’s platform provides independent music artists with a 360-degree solution that removes gatekeepers, middlemen, and 100% control of their music remains with them. The…

FridayAug 26, 2022 11:39 am

QualityStocksNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Announces Participation in Upcoming RBC Capital Markets Global Industrials Conference

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, will be participating in the RBC Capital Markets Global Industrials Conference. The conference is scheduled for Sept. 13–14, 2022, in Las Vegas. Cepton’s chief financial officer Hull Xu will be hosting a breakout session during the two-day event; the session is slated to begin at 9:05 a.m. PT on Sept. 14. In addition, Cepton management will also be hosting investor meetings throughout the conference. To view the full press release, visit https://ibn.fm/bAILp About Cepton Technologies Inc. Cepton is a Silicon Valley innovator of lidar-based solutions for automotive (“ADAS/AV”),…

FridayAug 26, 2022 11:29 am

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Record Revenue for Q2 2022

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for B2B cross-border shipping in the NAFTA region, today announced its revenue for the second quarter of 2022 for the period ended June 30, 2022. Among the highlights, Fr8Tech reported record quarterly revenue of $8.5 million for Q2 2022, up 60% from $5.3 million in Q1 2022 and up 45% from $5.9 million in Q2 2021. “Second quarter 2022 revenue, a record, increased 60% on a sequential quarter basis and 45% on a year-over-year basis,” said Fr8Tech…

FridayAug 26, 2022 11:09 am

QualityStocksNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTC: LQWDF) Releases Results from Annual General Meeting

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), a company focused on building infrastructure on the Bitcoin Lightning Network global micropayment system, is reporting on the voting results of its 2022 annual general meeting of shareholders. The meeting was held on Aug. 24, 2022. Shareholders voted on the election of directors as well as the appointment of auditors and a proposed stock-option plan. According to the announcement, all four of the nominees listed in LQwD's management information circular and proposed by management for election to the board of directors were duly elected. Those individuals included Shone Anstey, Giuseppe (Pino) Perone, Kim Evans…

ThursdayAug 25, 2022 1:35 pm

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Receives ‘Marketable Advantage’ Toward Manufacturing, Supply Chain of CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) recently received a key patent for its exclusive radiopharmaceutical drug candidate, CycloSam(R), from the U.S. Patent & Trademark Office. “The patent protects how CycloSam is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration site and provides for high purity in an efficient, facile and reproducible process at lower costs… The scope of this patent is fairly broad in that it not only protects the use of QSAM’s primary radioisotope, Samarium-153 (Sm-153), but also several other radioactive materials used in commercialized radiopharmaceuticals such as Lutetium-177 (Lu-177)…

ThursdayAug 25, 2022 1:25 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Fusing Traditional Therapeutics with Psychedelic Research

Silo Pharma (OTCQB: SILO) recently reported that the University of California San Francisco (“UCSF”) had successfully administered psilocybin to a test group of Parkinson’s disease patients. The psilocybin was administered “as part of a scientific research agreement (‘SRA’) entered with Silo in June 2021 to ‘determine the effects of psilocybin on inflammatory markers of patients who have exhibited Parkinson’s, bipolar disorder and chronic back pain,’” a recent article reads. According to Silo Pharma CEO Eric Weisblum, the company is encouraged by the progress and looks forward to the next cohort of patients receiving therapeutic treatment and sharing the analysis of…

Site Search

Company Search

Category: QualityStocksNewsBreaks